We are live on ! Find out more
RGEN icon

Repligen

447 hedge funds and large institutions have $7.74B invested in Repligen in 2023 Q2 according to their latest regulatory filings, with 64 funds opening new positions, 159 increasing their positions, 157 reducing their positions, and 61 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more call options, than puts

Call options by funds: $33.5M | Put options by funds: $27.4M

5% more first-time investments, than exits

New positions opened: 64 | Existing positions closed: 61

1% more repeat investments, than reductions

Existing positions increased: 159 | Existing positions reduced: 157

0.74% more ownership

Funds ownership: 97.46%98.2% (+0.74%)

0% more funds holding

Funds holding: 446447 (+1)

15% less capital invested

Capital invested by funds: $9.06B → $7.74B (-$1.32B)

40% less funds holding in top 10

Funds holding in top 10: 53 (-2)

Holders
447
Holders Change
+1
Holders Change %
+0.22%
% of All Funds
7.02%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.05%
New
64
Increased
159
Reduced
157
Closed
61
Calls
$33.5M
Puts
$27.4M
Net Calls
+$6.12M
Net Calls Change
-$8.2M

RGEN Hedge Fund Activity: Q2 2023 in Review

447 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Repligen (RGEN) for Q2 2023, worth a combined $7.74B — down 15% from $9.06B a quarter earlier.

Buyers outnumbered sellers: 64 funds opened new RGEN positions and 61 closed out — a net gain of 3 holders — while 159 added to existing stakes and 157 trimmed.

The largest buyer was BlackRock, adding an estimated $83.7M. The largest seller was Invesco, cutting an estimated $114M.

  • 447 institutional investors held Repligen (RGEN) as of Q2 2023, up from 446 in Q1 2023.
  • Funds reported $7.74B of Repligen stock for Q2 2023, down 15% quarter-over-quarter.
  • 64 funds opened new Repligen positions in Q2 2023 and 61 closed out, a net change of +3 holders.
  • The largest Repligen buyer in Q2 2023 was BlackRock, an estimated $83.7M added.
  • The largest Repligen seller in Q2 2023 was Invesco, an estimated $114M sold.

Based on aggregated 13F filings for Q2 2023.